We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+594.2%
AUM
$42.6B
AUM Growth
+$3.92B
Cap. Flow
+$2.21B
Cap. Flow %
5.18%
Top 10 Hldgs %
21.94%
Holding
6,155
New
1,425
Increased
1,766
Reduced
1,669
Closed
1,261

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.27%
2 Technology 2.76%
3 Financials 1.86%
4 Healthcare 1.62%
5 Communication Services 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMTI icon
4601
Rockwell Medical
RMTI
$27.2M
$98K ﹤0.01%
+181
New +$109K
MNOV icon
4602
MediciNova
MNOV
$63.5M
$97K ﹤0.01%
12,100
-83,222
-87% -$860K
GEN
4603
DELISTED
Genesis Healthcare, Inc.
GEN
$97K ﹤0.01%
+42,334
New +$81.8K
BLNK icon
4604
Blink Charging
BLNK
$67.5M
$95K ﹤0.01%
+18,483
New +$82.2K
APVO icon
4605
Aptevo Therapeutics
APVO
$4.96M
0
GST
4606
DELISTED
Gastar Exploration Inc.
GST
$94K ﹤0.01%
+168,451
New +$111K
ESV
4607
CALL
DELISTED
Ensco Rowan plc
ESV
$93K ﹤0.01%
3,200
+700
+28% +$17.1K
EYPT icon
4608
EyePoint Inc
EYPT
$999M
$92K ﹤0.01%
+4,434
New +$87K
SPWR
4609
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
$92K ﹤0.01%
18,324
-72,227
-80% -$396K
NEPT
4610
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$92K ﹤0.01%
+21
New +$84.5K
GNCA
4611
DELISTED
Genocea Biosciences, Inc.
GNCA
$92K ﹤0.01%
+13,388
New +$100K
GALT icon
4612
Galectin Therapeutics
GALT
$230M
$91K ﹤0.01%
+14,369
New +$70K
OCUL icon
4613
Ocular Therapeutix
OCUL
$1.83B
$91K ﹤0.01%
+13,489
New +$92.7K
AFH
4614
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$91K ﹤0.01%
+10,413
New +$111K
HIMX
4615
CALL
Himax Technologies
HIMX
$2.03B
$90K ﹤0.01%
12,000
-112,300
-90% -$830K
CLDX icon
4616
Celldex Therapeutics
CLDX
$2.94B
$89K ﹤0.01%
+11,808
New +$158K
GGB icon
4617
PUT
Gerdau
GGB
$9.54B
$89K ﹤0.01%
+31,500
New +$110K
SNES icon
4618
SenesTech
SNES
$6.74M
$88K ﹤0.01%
+1
New +$47.2K
ADXS
4619
DELISTED
Advaxis Inc
ADXS
$88K ﹤0.01%
+4,069
New +$105K
FG
4620
DELISTED
FGL Holdings Ordinary Shares
FG
$88K ﹤0.01%
10,497
-44,442
-81% -$405K
DEST
4621
DELISTED
Destination Maternity Corporation
DEST
$88K ﹤0.01%
+15,161
New +$52.6K
IVTY
4622
DELISTED
Invuity, Inc
IVTY
$88K ﹤0.01%
+22,637
New +$78.4K
PTGX icon
4623
Protagonist Therapeutics
PTGX
$8.55B
$87K ﹤0.01%
+12,945
New +$99.4K
BLDP
4624
Ballard Power Systems
BLDP
$754M
$86K ﹤0.01%
30,189
-3,952
-12% -$12.4K
BKCC
4625
DELISTED
BlackRock Capital Investment Corporation
BKCC
$84K ﹤0.01%
14,343
-9,615
-40% -$59.5K

Similar funds

Jane Street's Q2 2018 Portfolio in Review

As of Q2 2018, Jane Street held 6,155 positions worth $42.6B, up 10% from $38.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jane Street deployed $2.21B of net new capital in Q2 2018, opening 1,425 new positions and adding to 1,766 existing holdings. Its largest new stake was iShares MSCI EAFE Growth ETF: 330,065 shares worth $26M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.3% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $381M trimmed.

  • Jane Street's largest Q2 2018 buy was iShares MSCI EAFE Growth ETF: 330,065 shares worth $26M.
  • Jane Street added most to iShares Core MSCI Emerging Markets ETF in Q2 2018, an estimated $277M increase.
  • Jane Street's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $381M.
  • Jane Street fully exited iShares MBS ETF in Q2 2018, selling an estimated $136M.
  • Jane Street's ten largest holdings make up 22% of its $42.6B portfolio in Q2 2018.
  • Jane Street opened 1,425 new positions and closed 1,261 in Q2 2018.
  • Jane Street's portfolio value rose 10% quarter-over-quarter to $42.6B.

Based on Jane Street's 13F filing for Q2 2018, filed 15 Aug 2018.